News

NewBiologix has given a non-exclusive technology licence to Recipharm Advanced Bio to provide pharma companies access to ...
Logistics providers can considerably ease the challenges of transporting essential and time-sensitive medicines along pharma ...
As part of its coverage of both the International Day of Women and Girls in Science on February 11 and International Women’s Day on March 8, Pharmaceutical Technology® conducted a series of interviews ...
Eli Lilly has filed a lawsuit against four telehealth platforms selling compounded versions of its blockbuster metabolic disorder drug tirzepatide, marking the latest power struggle between weight ...
In this exclusive Drug Digest video interview, Felicity Thomas, Associate Editorial Director, Pharmaceutical Technology Group, interviews experts about key trends impacting small-molecule APIs and ...
Rodica Ceslov explores the challenges associated with social media in the pharmaceutical industry and the benefits of pushing through those barriers and using social media effectively. Social ...
In the evolving landscape of distributed database systems, the digital transformation of the pharmaceutical industry is ...
Amneal Pharmaceuticals, Inc. (Nasdaq: AMRX) ("Amneal” or the "Company”), an American biopharmaceutical company, and Apiject ...
Learn how space-based manufacturing is transforming pharmaceuticals with Varda's innovative approach to drug production in ...
NGES 4.0 leverages AI technology to enhance efficiency, refine management, and ensure compliance across various ...
President Donald Trump announced his plan to sign an executive order on Monday through a post on Truth Social on Sunday evening.
Artisan Partners, an investment management company, released its “Artisan Mid Cap Fund” first quarter 2025 investor letter. A ...